SE464683B - Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e - Google Patents

Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Info

Publication number
SE464683B
SE464683B SE8403659A SE8403659A SE464683B SE 464683 B SE464683 B SE 464683B SE 8403659 A SE8403659 A SE 8403659A SE 8403659 A SE8403659 A SE 8403659A SE 464683 B SE464683 B SE 464683B
Authority
SE
Sweden
Prior art keywords
phosphate
vitamin
aica
treatment
liver
Prior art date
Application number
SE8403659A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403659D0 (sv
SE8403659L (sv
Inventor
J Schawartz
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE8403659D0 publication Critical patent/SE8403659D0/xx
Publication of SE8403659L publication Critical patent/SE8403659L/xx
Publication of SE464683B publication Critical patent/SE464683B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8403659A 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e SE464683B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU832463A HU190597B (en) 1983-07-11 1983-07-11 Process for preparing synrtgetic pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8403659D0 SE8403659D0 (sv) 1984-07-10
SE8403659L SE8403659L (sv) 1985-01-12
SE464683B true SE464683B (sv) 1991-06-03

Family

ID=10959498

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403659A SE464683B (sv) 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Country Status (11)

Country Link
US (1) US4581348A (it)
AT (1) AT389052B (it)
BE (1) BE900125A (it)
CA (1) CA1238576A (it)
CH (1) CH661866A5 (it)
DE (1) DE3425466A1 (it)
FR (1) FR2548900B1 (it)
GB (1) GB2144417B (it)
HU (1) HU190597B (it)
IT (1) IT1214843B (it)
SE (1) SE464683B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204097A (en) * 1977-02-25 1980-05-20 Schmit John W Lockable covering apparatus for telephone dials
US4396810A (en) * 1979-12-03 1983-08-02 Cover Hunter H Pushbutton telephone dial locks
DE3711640A1 (de) * 1987-04-07 1988-10-27 Hollingsworth Gmbh Vorrichtung zum reinigen und oeffnen von textil-fasergut
US5622991A (en) * 1994-08-30 1997-04-22 Cornell Research Foundation, Inc. Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats
US5728707A (en) * 1995-07-21 1998-03-17 Constantia Gruppe Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
DE69633566T2 (de) * 1995-07-21 2005-12-08 Savvipharm Inc. Orotatsalze von 5-amino- oder substituierten amino-1,2,3-triazolen zur behandlung von neoplasmen
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210865B (de) * 1962-03-05 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung des 2, 6-dioxo-tetrahydropyrimidin-4-carbonsauren Salzes des 4-Amino-5-imidazolcarbonsaeureamids
US4182770A (en) * 1976-10-09 1980-01-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Alcohol deterrent
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物

Also Published As

Publication number Publication date
HU190597B (en) 1986-09-29
SE8403659D0 (sv) 1984-07-10
HUT34122A (en) 1985-02-28
FR2548900A1 (fr) 1985-01-18
BE900125A (fr) 1984-11-05
DE3425466A1 (de) 1985-01-24
GB2144417A (en) 1985-03-06
IT1214843B (it) 1990-01-18
FR2548900B1 (fr) 1988-12-09
SE8403659L (sv) 1985-01-12
CH661866A5 (de) 1987-08-31
GB2144417B (en) 1986-10-22
GB8417677D0 (en) 1984-08-15
AT389052B (de) 1989-10-10
ATA220684A (de) 1989-03-15
IT8467682A0 (it) 1984-07-04
US4581348A (en) 1986-04-08
CA1238576A (en) 1988-06-28

Similar Documents

Publication Publication Date Title
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
EP1378238A1 (en) Pharmaceutical compositions containing donepezil hydrochloride
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE2728685A1 (de) Arzneimittel
KR102600879B1 (ko) 세포 내 atp 증강제
DE3785740T2 (de) Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.
SE464683B (sv) Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e
Sioufi et al. The effect of age on the pharmacokinetics of valsartan
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
Weinberg et al. Modulation of cell nucleotide levels of isolated kidney tubules
DE60212757T2 (de) Verfahren zur Verwendung von Pyrrolederivaten gegen Zwangsstörungen
EP0278449B1 (en) Agent having renal function-improving effect and diuretic effect and the use of a benzothiazepin derivative contained therein
LU87331A1 (fr) Orale magnesium und kalium enthaltende praeparate und deren verwendung
DE60212415T2 (de) Die verwendung von einer 4-pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE602004012593T2 (de) Kombinationen aus valsartan, amilorid oder triamterin und einem diuretikum
CN1146420C (zh) [R－（Z）]-a-（甲氧基亚氨基）-a-（1－氮杂双环[2.2.2]辛－3－基）乙腈在制备治疗精神病的药物中的应用
Giri et al. The effect of paraquat on guanylate cyclase activity in relation to morphological changes of guinea pig lungs
Hughes et al. Chronic leukopenia associated with carbamazepine and other antiepileptic drugs
DE3324785C2 (de) Pharmazeutische Zubereitung mit synergistischer antihypertensiver Wirkung
EP0123841B1 (de) Arzneimittel mit einer die atheroprotektiven High Density Lipoproteine steigernden Wirkung, enthaltend 2,6-Bis-diäthanolamino-4,8-dipiperidino-pyrimido (5,4-d)-pyrimidin
CN101252925B (zh) 以逆转录酶抑制剂和美度铵为基础的药物组合物
EP0208962B1 (de) Kombinationspräparate aus Hemmstoffen der Thrombozytenaggregation und deren Verwendung
DE69427927T2 (de) Verwendung von Trimetazidin zur Herstellung von Medikamenten für die Behandlung von Gesundheitsstörungen, die durch die Nephrotoxizität von Cyclosporin A bedingt sind.
JPS6366285B2 (it)
US4499106A (en) Lipolytic composition and method of treating obesity

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8403659-9

Effective date: 19930204

Format of ref document f/p: F